On Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q2 2023 earnings per share (EPS) of -$0.87, up 99% year over year. Total Aprea Therapeutics earnings for the quarter were -$3.26 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$86.72.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.